The effect of metformin usage on survival outcomes for hepatocellular carcinoma patients with type 2 diabetes mellitus after curative therapy

HIGHLIGHTS

• who: Bo Yuan from the Pondicherry University, India have published the paper: The effect of metformin usage on survival outcomes for hepatocellular carcinoma patients with type 2 diabetes mellitus after curative therapy, in the Journal: (JOURNAL) of 31/05/2022
• future: The results from this study revealed that metformin usage can significantly prolong the 3-year (OR=1.50 95% CI 1.22-1.83 p=0.000) and 5-year (OR=1.88 95% CI 1.47-2.41 p=0.000) OS and decrease the 1-year (OR=1.31 95% CI 1 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.